GlassScriptPhysician profile
Alexandra Williams
NPI 1427161066
$5,962.32
in general payments reported to CMS, 2019-2025
47 companies · $1,912 in 2025
The $1,912 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $62.70 · 2021: $165 · 2022: $1,046 · 2023: $1,257 · 2024: $1,376 · 2025: $1,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,480 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,479.87 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $569.07 | 2025 | Daxxify |
| Novo Nordisk INC | $557.10 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $499.43 | 2021-2025 | Repatha, Otezla, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $335.55 | 2022-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $330.33 | 2022-2025 | |
| Pfizer INC. | $296.57 | 2022-2025 | |
| Exact Sciences Corporation | $285.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $269.03 | 2022-2025 | Mounjaro, Kisunla, Jardiance |
| Astrazeneca Pharmaceuticals LP | $266.57 | 2020-2025 | Breztri, Airsupra, Fasenra |
| United Therapeutics Corporation | $193.76 | 2022-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $180.13 | 2022-2023 | Opsumit, Uptravi |
| Idorsia Pharmaceuticals US INC | $178.58 | 2023-2025 | Quviviq, Quviviq |
| Merck Sharp & Dohme LLC | $166.32 | 2021-2025 | Winrevair, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $154.24 | 2022-2025 | Glassia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.03 | 2022-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $144.75 | 2022-2024 | Trelegy Ellipta, Nucala, Shingrix |
| Boston Scientific Corporation | $121.24 | 2019 | |
| Stryker Corporation | $118.55 | 2024 | T2 |
| Abbott Laboratories | $111.58 | 2019-2021 | |
| Insmed, INC. | $104.82 | 2022-2025 | Arikayce |
| Sumitomo Pharma America, INC. | $73.17 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $65.85 | 2022-2023 | Xarelto |
| Baxter Healthcare | $65.55 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $59.19 | 2022-2023 | Nuzyra |
| Shield Therapeutics INC | $58.48 | 2024-2025 | |
| Abbvie INC. | $49.12 | 2023-2024 | Ubrelvy |
| Covis Pharma Gmbh | $47.97 | 2022 | |
| Alnylam Pharmaceuticals INC. | $45.57 | 2024-2025 | Onpattro |
| Axsome Therapeutics, INC. | $45.23 | 2025 | Auvelity |
| Medtronic, INC. | $40.79 | 2021 | |
| Electromed, INC. | $36.85 | 2022-2025 | Smartvest |
| Gilead Sciences, INC. | $35.90 | 2023-2024 | Veklury |
| Ucb, INC. | $34.94 | 2024 | Nayzilam |
| Itamar Medical INC | $33.40 | 2025 | Watchpatone |
| Inspire Medical Systems, INC. | $27.72 | 2025 | Inspire |
| Radius Health, INC. | $25.33 | 2022 | |
| Optinose US, INC. | $23.94 | 2022 | |
| Medtronic Vascular, INC. | $23.13 | 2020 | |
| Astellas Pharma US INC | $19.49 | 2025 | Veozah |
| Philips North America LLC | $19.30 | 2025 | Event |
| Tris Pharma INC | $17.39 | 2024 | Dyanavel Xr |
| Cleerly, INC. | $16.78 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Mylan Specialty L.P. | $14.27 | 2023 | Yupelri |
| Phathom Pharmaceuticals, INC. | $14.10 | 2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $14.01 | 2022 | |
| Medicure Pharma INC. | $13.68 | 2025 | Zypitamag |
| Nestle Healthcare Nutrition INC. | $12.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.